RUNX2 and breast cancer: Our group has reported that CTSK is a direct transcriptional target of RUNX2, a master mediator of the BMP/SMAD signaling for bone development and remodeling, and that CTSK is coexpressed with a set of BRGs regulated by RUNX2 in primary breast cancer tissues20.